Results 11 to 20 of about 4,931,245 (245)

Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2016
Objective(s):Long-term treatment with antipsychotics causes serious side effects such as tardive dyskinesia that characterized by abnormal movements in the orofacial region. Oxidative stress in the brain specific area is implicated in the pathophysiology
Marzyeh Kamyar   +5 more
doaj   +3 more sources

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease

open access: yesTherapeutics and Clinical Risk Management, 2018
Vibhash D Sharma, Kelly E Lyons, Rajesh Pahwa Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA Abstract: Levodopa-induced dyskinesia (LID) is a common motor complication in patients with Parkinson’s disease on ...
Sharma VD, Lyons KE, Pahwa R
doaj   +1 more source

New insights into the mechanism of drug-induced dyskinesia

open access: yesCNS Spectrums, 2012
Dyskinesia is an extrapyramidal movement disorder characterized by involuntary, repetitive, irregular motions that affect the mouth and face and/or the limbs and trunk. Tardive dyskinesia (TD) is a well-known complication of long-term treatment with antipsychotic drugs.
Loonen, Anton J. M.   +1 more
openaire   +3 more sources

Co‐Expression of Tardive Dyskinesia and Drug‐Induced Parkinsonism in Rats Chronically Treated With Haloperidol [PDF]

open access: yesNeuropsychopharmacology Reports
Aim We aimed to create a rat model of drug‐induced parkinsonism and tardive dyskinesia by chronic administration of haloperidol and examine the expression of direct and indirect pathway markers in the striatum of the model rats.
Iku Kinoshita   +7 more
doaj   +3 more sources

Efficacy of low-dose pramipexole augmentation in the treatment of refractory psychotic depression complicated with tardive dyskinesia: a case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Tardive dyskinesia (TD) is a severe complication of antipsychotic treatment. Pramipexole can be effective in the treatment of TD due to its D3 dopamine receptor agonist effect.
Arzu Erkan   +3 more
doaj   +1 more source

Failure of pyridoxine to reduce drug-induced dyskinesias [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 1970
The use of pyridoxine seems to be ineffective in reducing tardive dyskinesia.
G E, Crane, I S, Turek, A A, Kurland
openaire   +2 more sources

Primary ciliary dyskinesia (Siewert's/Kartagener's syndrome): respiratory symptoms and psycho-social impact [PDF]

open access: yes, 2003
Although the pathophysiological defect in primary ciliary dyskinesia (PCD; Siewert's/Kartagener's syndrome) is now well characterised, there are few studies of the impact of the condition upon health function, particularly in later life.
I Christopher McManus   +14 more
core   +2 more sources

Anticholinergic Agents Can Induce Oromandibular Dyskinesia [PDF]

open access: yesJournal of Movement Disorders, 2009
Background and Purpose: Oromandibular dyskinesia (OMD) can occur spontaneously or they can be induced by the conventional dopamine receptor antagonists.
Hee-Young Shin   +2 more
doaj   +1 more source

Tardive dyskinesia: Prevention and newer management strategies

open access: yesAnnals of Indian Psychiatry, 2020
Tardive dyskinesia (TD) is a condition where we have a limited understanding of the cause and of management. The delayed-onset movements can occur due to prolonged exposure to dopamine receptor-blocking agents (DRBAs).
Sreelakshmi Vaidyanathan   +1 more
doaj   +1 more source

Tardive dyskinesia on clozapine: A case report

open access: yesSouth African Journal of Psychiatry, 2009
Antipsychotic-induced tardive dyskinesia is a potentially irremediable and debilitating condition with the onset most commonly associated with the use of first-generation antipsychotics.
Laila Asmal
doaj   +1 more source

Home - About - Disclaimer - Privacy